Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence
Main Authors: | Harpreet Kaur, Inderpaul Singh Sehgal, Navneet Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Lung India |
Online Access: | http://www.lungindia.com/article.asp?issn=0970-2113;year=2016;volume=33;issue=4;spage=470;epage=472;aulast=Kaur |
Similar Items
-
Intraventricular chemotherapy and nonsmall cell lung carcinoma
by: Jamir Pitton Rissardo, et al.
Published: (2019-01-01) -
Comparison of Sleep Quality before and after Chemotherapy in Locally Advanced Nonsmall Cell Lung Cancer Patients: A Prospective Study
by: N. Belloumi, et al.
Published: (2020-01-01) -
Metastatic calcification in end-stage renal disease: Contra naturam
by: Inderpaul Singh Sehgal, et al.
Published: (2020-01-01) -
Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
by: Arafat Tfayli, et al.
Published: (2020-11-01) -
Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
by: J.B. Sorensen, et al.
Published: (2011-03-01)